Antibody-mediated Delivery of Protein Degraders
Time: 12:00 pm
day: Track A - Pre-Conf - PM
Details:
- Discussing efforts to expand ADC technology outside of pancytotoxics
- Assessing the impact of DAR and payload potency on ADC activity
- Optimizing linker-drug structure for improved pharmacokinetic properties
